John Erdner News Today

As much that went right for Jujubee in 2021, is as much that has gone wrong for the four-year-old trotting stallion in 2022.

10/27/22 Pharmaceutical Online Newsletter

08/05/22 Pharmaceutical Online Newsletter

Top U.S. trotter Jujubee is preparing for his four-year-old campaign that will keep him focused on tackling the North American competition as his connections have declined an invitation to the Elitloppet, according to a local article.

01/04/22 Pharmaceutical Online Newsletter

12/10/21 Pharmaceutical Online Newsletter

11/02/21 Pharmaceutical Online Newsletter

There are several methods for validating the cleaning effectiveness of washers, but all include some sort of contamination and then an evaluation of...

Many innovative pharmaceutical packaging formats are being developed to meet the growing requirement for sterile, safe and secure packaging and...

03.09.21 -- Incorporating Excipients Into QbD Studies For Drug Development -- An Introduction     Orphan drugs are notorious for their high costs and risk factors, which are attributed to smaller patient pools and higher development and launch costs.   Attend this webinar to learn more about key trends that are causing the rise of orphan drug indications, fast-tracking early development phases that will lead to commercial success, and more!     By Brian Ca...